Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
https://youtu.be/vMIy8xWLOKI?t=3699
Starts at 1 Hour Mark.
INSIDER HOLDINGS
Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.
Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again..
The Microsoft co-founder...
Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.
The 2021 Biotech Six Pack, Six Stocks We Expect to Double.
We're still putting the 2021 list together now,...
Make Hay While the Sun Shines. Up 6,400%.
Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...
Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...
Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...
PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...
Citius (CTXR) Announces Results of Mino-Lok Study.
"Mino-Lok has the potential to change the standard of care, which currently calls for a procedure to remove and replace the infected...
Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...
PITTSFORD, N.Y., Nov. 12, 2020
PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.
LIVE QUOTE
Adding Dalrada (DFCO), a technology Incubator with interests in telehealth and...
Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.
LIVE QUOTE
Of course, we need not have to say, this is not an idea for widows...
Latest article
Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.
119% Gain Post Split
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
